ZA915565B - Preparation process of sustained release compositions and the compositions thus obtained - Google Patents

Preparation process of sustained release compositions and the compositions thus obtained

Info

Publication number
ZA915565B
ZA915565B ZA915565A ZA915565A ZA915565B ZA 915565 B ZA915565 B ZA 915565B ZA 915565 A ZA915565 A ZA 915565A ZA 915565 A ZA915565 A ZA 915565A ZA 915565 B ZA915565 B ZA 915565B
Authority
ZA
South Africa
Prior art keywords
compositions
preparation process
sustained release
release compositions
sustained
Prior art date
Application number
ZA915565A
Other languages
English (en)
Inventor
Jean-Marc Ruiz
Ruiz Jean-Marc
Original Assignee
Scras
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Scras filed Critical Scras
Publication of ZA915565B publication Critical patent/ZA915565B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
    • A61K9/1647—Polyesters, e.g. poly(lactide-co-glycolide)

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Biological Depolymerization Polymers (AREA)
  • Glanulating (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
  • Cosmetics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
ZA915565A 1990-08-01 1991-07-16 Preparation process of sustained release compositions and the compositions thus obtained ZA915565B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB909016885A GB9016885D0 (en) 1990-08-01 1990-08-01 Sustained release pharmaceutical compositions

Publications (1)

Publication Number Publication Date
ZA915565B true ZA915565B (en) 1992-04-29

Family

ID=10679993

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA915565A ZA915565B (en) 1990-08-01 1991-07-16 Preparation process of sustained release compositions and the compositions thus obtained

Country Status (30)

Country Link
US (1) US5213812A (da)
JP (1) JP2818704B2 (da)
KR (1) KR920003962A (da)
AT (1) AT396425B (da)
AU (2) AU649696B2 (da)
BE (1) BE1004772A3 (da)
CA (1) CA2048270C (da)
CH (1) CH682715A5 (da)
DE (1) DE4125542A1 (da)
DK (1) DK175756B1 (da)
ES (1) ES2046083B1 (da)
FI (1) FI104149B (da)
FR (1) FR2665360B1 (da)
GB (1) GB9016885D0 (da)
GR (1) GR1001512B (da)
HK (1) HK33294A (da)
IE (1) IE65124B1 (da)
IN (1) IN178446B (da)
IT (1) IT1251788B (da)
LU (1) LU87982A1 (da)
MA (1) MA22245A1 (da)
MY (1) MY107500A (da)
NL (1) NL194637C (da)
NO (1) NO300158B1 (da)
NZ (1) NZ238981A (da)
OA (1) OA09387A (da)
PT (1) PT98497B (da)
SE (1) SE505734C2 (da)
TN (1) TNSN91067A1 (da)
ZA (1) ZA915565B (da)

Families Citing this family (60)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6090925A (en) 1993-03-09 2000-07-18 Epic Therapeutics, Inc. Macromolecular microparticles and methods of production and use
US5569467A (en) * 1993-05-15 1996-10-29 Societe De Conseils De Recherches Et D'applications (S.C.R.A.S.) Process for the preparation of microballs and microballs thus obtained
GB9310030D0 (en) * 1993-05-15 1993-06-30 Scras Dry processed particles and process for the preparation of the same
DE69529054T2 (de) * 1994-02-28 2003-08-21 Nanopharm Ag System zur gezielten wirkstoffzufuhr, verfahren zu seiner herstellung und verwendung
US5980945A (en) * 1996-01-16 1999-11-09 Societe De Conseils De Recherches Et D'applications Scientifique S.A. Sustained release drug formulations
DE19604744A1 (de) 1996-02-09 1997-08-14 Henkel Kgaa Technische Di-/Triglyceridgemische
DE19617137C1 (de) * 1996-04-29 1997-02-27 Henkel Kgaa Verwendung von Copolymerestern für die Herstellung von Mikrosphären
EP0930874A2 (en) * 1996-10-09 1999-07-28 Takeda Chemical Industries, Ltd. A method for producing a microparticle
MY118835A (en) * 1997-04-18 2005-01-31 Ipsen Pharma Biotech Sustained release compositions and the process for their preparation
AU3555599A (en) 1998-04-13 1999-11-01 Luminex Corporation Liquid labeling with fluorescent microparticles
EE200100314A (et) * 1998-12-16 2002-08-15 Aventis Pharmaceuticals Inc. Meetod farmatseutilise kompositsiooni valmistamiseks, farmatseutiline kompositsioon ja selle kasutamine
AU5644400A (en) * 1999-09-24 2001-03-29 Rohm And Haas Company Pellet compositions
US6458387B1 (en) * 1999-10-18 2002-10-01 Epic Therapeutics, Inc. Sustained release microspheres
US7374782B2 (en) 2000-10-27 2008-05-20 Baxter International Inc. Production of microspheres
WO2003015750A1 (en) * 2001-08-16 2003-02-27 Baxter International, Inc. Propellant-based microparticle formulations
US20080026068A1 (en) * 2001-08-16 2008-01-31 Baxter Healthcare S.A. Pulmonary delivery of spherical insulin microparticles
US20040166077A1 (en) * 2002-12-04 2004-08-26 L'oreal Process for treating keratin materials with aromatic active principles
FR2848113B1 (fr) * 2002-12-04 2005-02-25 Oreal Stabilisation de principes actifs aromatiques par des polymeres aromatiques
US20070092452A1 (en) * 2003-07-18 2007-04-26 Julia Rashba-Step Methods for fabrication, uses, compositions of inhalable spherical particles
KR101137785B1 (ko) * 2003-07-18 2012-04-25 백스터 인터내셔널 인코포레이티드 제어된 상 분리에 의해 제조된 작은 구형 입자의 제조방법, 이용 방법 및 조성물
US20050142205A1 (en) * 2003-07-18 2005-06-30 Julia Rashba-Step Methods for encapsulating small spherical particles prepared by controlled phase separation
WO2005009375A2 (en) * 2003-07-22 2005-02-03 Baxter International Inc. Small spherical particles of low molecular weight organic molecules and methods of preparation and use thereof
US20060135277A1 (en) * 2003-09-10 2006-06-22 Marnocha Bendict F Golf club and practice arrangement
FR2865938B1 (fr) * 2004-02-05 2006-06-02 Sod Conseils Rech Applic Formulation retard solide comprenant de l'acetate de triptoreline
DK1765294T3 (da) * 2004-05-12 2008-11-10 Baxter Int Nukleinsyremikrokugler samt deres fremstilling og afgivelse
US7884085B2 (en) * 2004-05-12 2011-02-08 Baxter International Inc. Delivery of AS-oligonucleotide microspheres to induce dendritic cell tolerance for the treatment of autoimmune type 1 diabetes
EP1753404A1 (en) * 2004-05-12 2007-02-21 Baxter International Inc. Microspheres comprising protein and showing injectability at high concentrations of said agent
US8728525B2 (en) * 2004-05-12 2014-05-20 Baxter International Inc. Protein microspheres retaining pharmacokinetic and pharmacodynamic properties
WO2006017336A2 (en) * 2004-07-13 2006-02-16 Altairnano, Inc. Ceramic structures for prevention of drug diversion
US20060165787A1 (en) * 2004-07-13 2006-07-27 Moerck Rudi E Ceramic structures for controlled release of drugs
EP1812920A1 (en) * 2004-10-29 2007-08-01 Adhesives Research, Inc. Microscopic tagging system for security identification
MX2007013356A (es) * 2005-04-27 2008-03-26 Baxter Int Microparticulas modificadas en la superficie y metodos de formacion y uso de las mismas.
EP1928814A2 (en) * 2005-08-23 2008-06-11 Altairnano, Inc HIGHLY PHOTOCATALYTIC PHOSPHORUS-DOPED ANATASE-TiO2 COMPOSITION AND RELATED MANUFACTURING METHODS
US20080038482A1 (en) * 2006-03-02 2008-02-14 Fred Ratel Method for Low Temperature Production of Nano-Structured Iron Oxide Coatings
US20080020175A1 (en) * 2006-03-02 2008-01-24 Fred Ratel Nanostructured Indium-Doped Iron Oxide
WO2007103824A1 (en) * 2006-03-02 2007-09-13 Altairnano, Inc. Nanostructured metal oxides
US20070281031A1 (en) * 2006-06-01 2007-12-06 Guohan Yang Microparticles and methods for production thereof
JP5118139B2 (ja) 2006-08-04 2013-01-16 バクスター・インターナショナル・インコーポレイテッド 新規発症自己免疫性糖尿病を予防および／または逆転させるためのマイクロスフィアに基づく組成物
EP2068845A2 (en) * 2006-10-06 2009-06-17 Baxter International Inc. Microencapsules containing surface-modified microparticles and methods of forming and using the same
US9017697B2 (en) 2006-10-12 2015-04-28 The University Of Queensland Compositions and methods for modulating immune responses
US20090169628A1 (en) * 2006-10-17 2009-07-02 Armark Authentication Technologies, Llc Article and method for focused delivery of therapeutic and/or diagnostic materials
WO2008128000A1 (en) * 2007-04-12 2008-10-23 Altairnano, Inc. Teflon replacements and related production methods
MX2009011218A (es) * 2007-04-17 2010-02-11 Baxter Int Microparticulas de acido nucleico para administracion pulmonar.
US9782300B2 (en) 2008-02-01 2017-10-10 Kci Licensing, Inc. Fiber-microsphere bioresorbable composite scaffold for wound healing
AU2009237577B2 (en) 2008-04-18 2014-06-05 Baxter Healthcare Sa Microsphere-based composition for preventing and/or reversing new-onset autoimmune diabetes
US8323685B2 (en) * 2008-08-20 2012-12-04 Baxter International Inc. Methods of processing compositions containing microparticles
US8367427B2 (en) * 2008-08-20 2013-02-05 Baxter International Inc. Methods of processing compositions containing microparticles
US20100047292A1 (en) * 2008-08-20 2010-02-25 Baxter International Inc. Methods of processing microparticles and compositions produced thereby
US8323615B2 (en) * 2008-08-20 2012-12-04 Baxter International Inc. Methods of processing multi-phasic dispersions
WO2010037021A2 (en) * 2008-09-29 2010-04-01 Armark Authentication Technologies, Llc Spinneret and method of spinning fiber
US20100291214A1 (en) * 2008-12-23 2010-11-18 Armark Authentication Technologies, Llc Three-dimensional microfiber extrudate structure and process for forming three-dimensional microfiber extrudate structure
US20100291384A1 (en) * 2009-05-15 2010-11-18 Armark Authentication Technologies, Llc Fiber having non-uniform composition and method for making same
MX2011012597A (es) 2009-05-27 2012-04-19 Selecta Biosciences Inc Nanoportadores que poseen componentes con diferentes tasas de liberacion.
WO2011038053A1 (en) * 2009-09-25 2011-03-31 Armark Authentication Technologies, Llc Tissue fiber scaffold and method for making
CN107080839A (zh) 2010-05-26 2017-08-22 西莱克塔生物科技公司 多价的合成纳米载体疫苗
EP2399931A1 (fr) * 2010-06-22 2011-12-28 Ipsen Pharma S.A.S. Nouveaux composés octapeptidiques et leur utilisation thérapeutique
AU2011325857A1 (en) 2010-11-01 2013-05-02 University Of Technology, Sydney Immune-modulating agents and uses therefor
CN103702687A (zh) 2011-07-29 2014-04-02 西莱克塔生物科技公司 产生体液和细胞毒性t淋巴细胞（ctl）免疫应答的合成纳米载体
AU2015268101B2 (en) 2014-05-27 2021-01-28 The University Of Queensland Modulation of cellular stress
FR3067226B1 (fr) * 2017-06-13 2021-10-08 Rossignol Lange Element de chaussure de ski

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3567650A (en) * 1969-02-14 1971-03-02 Ncr Co Method of making microscopic capsules
US4010125A (en) * 1975-06-12 1977-03-01 Schally Andrew Victor [D-Trp6 ]-LH-RH and intermediates therefor
US4675189A (en) * 1980-11-18 1987-06-23 Syntex (U.S.A.) Inc. Microencapsulation of water soluble active polypeptides
IE52535B1 (en) * 1981-02-16 1987-12-09 Ici Plc Continuous release pharmaceutical compositions
JPS60100516A (ja) * 1983-11-04 1985-06-04 Takeda Chem Ind Ltd 徐放型マイクロカプセルの製造法
IN167096B (da) * 1985-04-04 1990-09-01 Akzo Nv
US4666705A (en) * 1985-06-03 1987-05-19 E. R. Squibb & Sons, Inc. Controlled release formulation
GB8628728D0 (en) * 1986-12-02 1987-01-07 Euro Celtique Sa Spheroids
GB8705083D0 (en) * 1987-03-04 1987-04-08 Euro Celtique Sa Spheroids
AU4369589A (en) * 1988-10-27 1990-05-03 Abbott Laboratories Controlled-release delivery device, method for producing device, and method of using device

Also Published As

Publication number Publication date
FR2665360A1 (fr) 1992-02-07
AU8146691A (en) 1992-02-06
JP2818704B2 (ja) 1998-10-30
PT98497B (pt) 1997-10-31
BE1004772A3 (fr) 1993-01-26
ATA152591A (de) 1993-01-15
AU666808B2 (en) 1996-02-22
DK141891A (da) 1992-02-02
NL194637B (nl) 2002-06-03
NO912986L (no) 1992-02-03
JPH05178740A (ja) 1993-07-20
KR920003962A (ko) 1992-03-27
GR910100330A (en) 1992-08-31
SE505734C2 (sv) 1997-10-06
ITMI911953A0 (it) 1991-07-15
FR2665360B1 (fr) 1995-02-10
ES2046083B1 (es) 1994-08-01
FI913646A (fi) 1992-02-02
TNSN91067A1 (fr) 1992-10-25
US5213812A (en) 1993-05-25
IN178446B (da) 1997-05-03
HK33294A (en) 1994-04-22
NL194637C (nl) 2002-10-04
SE9102249L (sv) 1992-02-02
CA2048270C (en) 1997-02-25
GR1001512B (el) 1994-02-28
NL9101306A (nl) 1992-03-02
DK141891D0 (da) 1991-07-31
OA09387A (fr) 1992-09-15
ES2046083A1 (es) 1994-01-16
IT1251788B (it) 1995-05-26
DE4125542A1 (de) 1992-02-06
NO300158B1 (no) 1997-04-21
NZ238981A (en) 1992-11-25
AT396425B (de) 1993-09-27
ITMI911953A1 (it) 1993-01-15
FI104149B1 (fi) 1999-11-30
AU5939394A (en) 1994-06-02
MY107500A (en) 1995-12-30
CA2048270A1 (en) 1992-02-02
LU87982A1 (fr) 1992-04-15
SE9102249D0 (sv) 1991-07-26
FI913646A0 (fi) 1991-07-31
PT98497A (pt) 1992-06-30
IE912700A1 (en) 1992-02-12
MA22245A1 (fr) 1992-04-01
AU649696B2 (en) 1994-06-02
CH682715A5 (fr) 1993-11-15
GB9016885D0 (en) 1990-09-12
IE65124B1 (en) 1995-10-04
FI104149B (fi) 1999-11-30
DK175756B1 (da) 2005-02-14
NO912986D0 (no) 1991-07-31

Similar Documents

Publication Publication Date Title
ZA915565B (en) Preparation process of sustained release compositions and the compositions thus obtained
GB2246786B (en) Preparation of polysuccinimide
EP0460741A3 (en) Preparation of aluminoxanes
EP0463555A3 (en) Preparation of aluminoxanes
EP0456062A3 (en) Process for preparation of isocyanuratepolyisocyanates, the compounds prepared according to this process, and their use
GB2258231B (en) Dry castable concrete compositions and methods of preparing and dry casting the same
GB9027902D0 (en) Preparation of foam-in-fabric articles
EP0510200A4 (en) Structure of release part
EP0483597A3 (en) Process of preparation of carebastin
IL97202A0 (en) Preparation of polyphosphazenes
ZA919751B (en) Catalyst compositions and process for the preparation of polymers
SG59871G (en) Controlled release compositions and use
NZ238916A (en) Preparation of 1-hydroxymethylpyrazoles
EP0439745A3 (en) Process for the preparation of 2-chloro-5-methyl-pyridine
GB9018839D0 (en) Slow release compositions
EP0444460A3 (en) Process for the preparation of acrolin
IL97512A0 (en) Process for the preparation of 1-hydroxyalkyl-5-nitro-imidazoles
EP0449778A3 (en) Process for the preparation of hydroxyphenylepropionates
NZ240279A (en) Preparation of
IL98877A0 (en) Process for the preparation of n-alkylsulfonylamino-sulfonylureas
GB9005839D0 (en) Preparation of fluoroanilines
GB9016062D0 (en) Process for the preparation of acrylates
EP0459242A3 (en) Process for the preparation of phenolethers
IL98876A0 (en) Process for the preparation of n-alkylsulfonyl aminosulfonylureas
NZ237062A (en) Preparation of cis-beta-lactams